October 17, 2024
TOPLINE: BARCELONA, Spain — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their primary care clinician may be less likely to adhere […]
October 17, 2024
AMSTERDAM — A new serum containing 2-mercaptonicotinoyl glycine (Melasyl) as its main ingredient was at least as good as, if not better than, cysteamine 5% cream […]
October 17, 2024
Docket Number: FDA-2020-D-2303 Issued by: Guidance Issuing Office Oncology Center of Excellence Center for Biologics Evaluation and Research Center for Drug Evaluation and Research This guidance […]
October 17, 2024
Docket Number: FDA-2017-D-5868 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research The Food and Drug Administration (FDA or Agency) is announcing the availability […]
October 17, 2024
TOPLINE: Fetuses exposed in utero to SARS-CoV-2 are not at an increased risk for neurodevelopmental problems in early childhood. METHODOLOGY: This prospective study aimed to assess […]
October 17, 2024
Background Nitrosamine drug substance-related impurities (NDSRIs) (a class of nitrosamines that are associated with or share structural similarity with the active pharmaceutical ingredient [API] of a […]
October 17, 2024
MADRID (Reuters) – The Madrid regional government on Thursday cancelled the traditional annual herding of flocks of sheep through the centre of the Spanish capital scheduled […]
October 17, 2024
(Reuters) – The Global Polio Eradication Initiative (GPEI) needs more funds and has pushed back by three years its target to officially wipe out all forms […]
October 17, 2024
Docket Number: FDA-2022-D-2061 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research This guidance is intended for holders of Type II active pharmaceutical ingredient […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626
Next page